Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Xantos Biomedicine AG has approved funding from the Bavarian Ministry of Economy

01 Dec 2005 - Xantos Biomedicine AG announced that it has been awarded a grant from the Bavarian Ministry of Economic Affairs, Infrastructure, Transport and Technology (=BayStMWIVT) for the expansion of its technology platform. The overall aim of the project, which will run for two years, is to create innovative applications for the Xantos' service technology platform. Several modules will be implemented and improved to increase the outcome of functional screenings.
 
In addition the project will aim at expanding the use of the OPERA System (Evotec Technologies), a high content screening tool, which is based on confocal microscopy, broadening the range of assays to be performed significantly. In addition to that further assays will be implemented to monitor the induced cellular phenotypes with complex intracellular biology. The second goal of this project will be to improve the access to Qiagen's RNAi libraries and implementing these libraries in various novel assays and optimizing this tool in combination with the traditional overexpression approach. As announced earlier this year Xantos has signed a comarketing agreement with Qiagen. The project and grants received will allow Xantos a highly competitive positioning of its service platform.